- Aug 4, 2000
- 29,307
- 2,099
- 126
I'm still down $279.11 on my BYSI put, Felix.
I may have to retire under a bridge somewhere.
I had to give up on that one. The shorts are completely convinced the FDA will reject their drug. The stock is now 75% sold short!!!
Currently its about $16, and decision date is no later than November 30th. If it gets rejected for lack of testing in America (mostly tested abroad), then you could be looking at a $2 stock or lower. I would suggest getting out now.
Its a shame too. Supposedly the drug eliminates the need for chemotherapy for certain types of patients.
Worst case they spend another year or two doing tests in America and stock goes back up from $2?
edit: The FDA has dont a lot of crazy things lately, like approve Biogens controversial Alzheimers drug. Assuming BYSI's drug pulls off a miracle and gets approved, I wonder what a stock with a 75% short ratio will open up at? I had to give up though, I figure too many people with experience watching the FDA are confident on rejection.
Last edited: